Source disclosure: February 05, 2026
SymBio Pharmaceuticals Limited [4582.T]
TOKYO, Feb 17 (Pulse News Wire) – Symbio Pharmaceuticals Limited (4582.T) reported consolidated results for fiscal year 2025 ending December. 31 billion (-46.7% YoY).
87 billion with an equity ratio of 23.9%. For the next fiscal year, the company forecasts 89 billion (+197.5%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms • Original filing💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.